Navigation Links
Being a smoker at time of prostate cancer diagnosis linked with increased risk of death
Date:6/21/2011

Men who are diagnosed with prostate cancer and who are also smokers have an associated increased risk of all-cause, cardiovascular and prostate cancer-specific death, according to a study in the June 22/29 issue of JAMA. These patients also had an increased likelihood of prostate cancer recurrence.

Accumulating evidence suggests that smoking may increase risk of aggressive prostate cancer and prostate cancer mortality. However, studies of smoking in relation to prostate cancer mortality or recurrence in prostate cancer patients are limited, with few prostate cancer-specific outcomes, according to background information in the article.

Stacey A. Kenfield, Sc.D., of the Harvard School of Public Health, Boston, and colleagues conducted a study to assess the relation of cigarette smoking and smoking cessation with overall, prostate cancer-specific, and cardiovascular disease (CVD) mortality and biochemical recurrence among men with prostate cancer. The study included 5,366 men diagnosed with prostate cancer between 1986 and 2006 in the Health Professionals Follow-Up Study.

Among the men diagnosed with prostate cancer, there were 1,630 deaths, 524 (32 percent) due to prostate cancer and 416 (26 percent) to CVD, and 878 biochemical recurrences. Analysis indicated that compared with never smokers, current smokers had an increased risk of dying from prostate cancer, CVD, and all-cause mortality and an increased risk of biochemical recurrence. A greater number of pack-years was associated with an increased risk of prostate cancer mortality, CVD mortality, and total mortality but not biochemical recurrence. Compared with current smokers, men who had quit smoking for 10 or more years had prostate cancer mortality risks similar to those who had never smoked.

The authors write that a direct effect of smoking on prostate cancer progression is biologically plausible, including tumor promotion through carcinogens from tobacco smoke; increased plasma levels of total and free testosterone, an androgen involved in the development and progression of prostate cancer in some smokers, with some studies reporting a dose-dependent association; epigenetic effects, including aberrant methylation profiles among current smokers, which correlate with aggressive disease; and nicotine-induced angiogenesis [formation of new blood vessels], capillary growth, and tumor growth and proliferation.

"In summary, smoking at the time of diagnosis was associated with substantially increased overall mortality and prostate cancer mortality and recurrence. Ten-year quitters had risks similar to never smokers. These results provide further support that smoking may increase risk of death from prostate cancer," the authors conclude.


'/>"/>

Contact: Marge Dwyer
mhdwyer@hsph.harvard.edu
617-432-8416
JAMA and Archives Journals
Source:Eurekalert

Related medicine news :

1. Anti-HIV gel being evaluated in pregnant and breastfeeding women
2. Being Born-Again Linked to More Brain Atrophy: Study
3. What do policymakers know about the factors influencing peoples well-being?
4. Biting back: Research could lead to mosquitoes being susceptible to diseases they transmit
5. Teen Boys With Autism at Risk of Being Bullied: Study
6. Being Housebound Linked to Alzheimers in Elderly
7. Effective pain management crucial to older adults well-being
8. Measles not being reported
9. Being in a good mood may lead to poor memory
10. DU researchers find that headway being made fighting communicable diseases globally
11. Report into well-being and inclusion of former politically motivated prisoners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... WASHINGTON, DC (PRWEB) , ... March 30, 2017 ... ... Truth. , On the eve of Autism Awareness Month, representatives from Organic ... Center, World Mercury Project, Focus For Health Foundation, A Voice for Choice, Moms ...
(Date:3/30/2017)... ... March 30, 2017 , ... Nutrition Education ... and Dietetics (AND), will join nonprofit Seafood Nutrition Partnership (SNP) in presenting “Eating ... designed to help nutrition educators and students inform consumers about the health benefits ...
(Date:3/30/2017)... ... March 30, 2017 , ... ... letter to President Trump expressing their support for an independent Vaccine Safety Commission. ... scientists and one medical journalist, will hold a press conference at 9:00 ...
(Date:3/29/2017)... WI (PRWEB) , ... March 29, 2017 , ... ARI ... its exclusive provider of co-op eligible dealer websites for its network of more than ... of professional landscaping and agricultural equipment including rotary and flail mowers and cutters, rear ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... professional squash, announced it has enlisted New York City-based sports and entertainment marketing ... develop and procure sponsorship opportunities for the Professional Squash Association (PSA), which includes ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... DUBLIN , Mar. 29, 2017 Research and ... Market, Reimbursement Policy, Patients Treated at Proton Therapy Centers & Forecast" ... ... 2021 from its current market size in 2016. The Untapped Proton Therapy ... than 1 Billion USD in 2016. Proton Therapy plays ...
(Date:3/29/2017)... 2017  Zynex (OTCQB: ZYXI), an innovative medical technology company ... devices for pain management, stroke rehabilitation, cardiac monitoring and ... Company,s 2016 full-year investor webcast on Monday, April 3, 2017 at 9:00 ... Company expects to file its 2016 full year financial ... ...
(Date:3/29/2017)... March 29, 2017 According to a new market ... (Gas-Filled Detectors, Geiger Muller, Survey Meter, Solid-State), Products (Personal Dosimeters, OSL, Badges), ... published by MarketsandMarkets, the market is expected to reach USD 1,215.4 Million ... 6.5% from 2016 to 2021. Continue Reading ... ...
Breaking Medicine Technology: